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A B S T R A C T   
The emergence of the novel coronavirus (SARS-CoV-2) and the worldwide spread of the coronavirus disease 
(COVID-19) have led to social regulations that caused substantial changes in manners of daily life. The subse-
quent loneliness and concerns of the pandemic during social distancing, quarantine, and lockdown are psy-
chosocial stressors that negatively affect the immune system. These effects occur through mechanisms controlled 
by the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenocortical (HPA) axis that alter 
immune regulation, namely the conserved transcriptional response to adversity (CTRA), which promotes 
inflammation and diminishes antiviral responses, leading to inadequate protection against viral disease. Un-
healthy eating habits, physical inactivity, sleep disturbances, and mental health consequences of COVID-19 add 
on to the pathological effects of loneliness, making immunity against this ferocious virus an even tougher fight. 
Therefore, social isolation, with its unintended consequences, has inherently paradoxical effects on immunity in 
relation to viral disease. Though this paradox can present a challenge, its acknowledgment can serve as an 
opportunity to address the associated issues and find ways to mitigate the adverse effects. In this review, we aim 
to explore, in detail, the pathological effects of the new social norms on immunity and present suggested methods 
to improve our physical, psychological, and healthcare abilities to fight viral infection in the context of the 
COVID-19 pandemic.   
1. Introduction 
With the emergence of a novel coronavirus, currently termed severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), since late 
December 2019, and the World Health Organization (WHO) declaration 
of this outbreak as a “public health emergency of international concern” 
on January 30, 2020, and consequently characterizing it as a pandemic 
on March 11, 2020, we are now in the midst of an unparalleled global 
situation, with catastrophic casualties (Hanaei and Rezaei, 2020; Jab-
bari et al., 2020a). As of December 15, 2020, over 122 million corona-
virus disease 2019 (COVID-19) cases and over 2.7 million deaths have 
been reported (Worldometers.info, 2020). 
As there existed no effective preventative measure in the face of this 
virus (Hanaei et al., 2020; Lotfi et al., 2020; Mohamed et al., 2020a; 
Mohamed et al., 2020b; Momtazmanesh et al., 2020; Moradian et al., 
2020a), such as a vaccine or other specific treatment (Basiri et al., 2020; 
Enriquez et al., 2019; Grant et al., 2020; Jahanshahlu and Rezaei, 2020a; 
Lotfi and Rezaei, 2020a; Mansourabadi et al., 2020; Mohamed et al., 
2021; Mojtabavi et al., 2020; Mueller et al., 2020; Pourahmad et al., 
2020; Rabiee et al., 2020; Raha et al., 2020; Rokni et al., 2020; 
Sadeghmousavi and Rezaei, 2020a; Saghazadeh and Rezaei, 2020a; 
Seyedpour, 2020; Sharifi et al., 2019; Torabi-Rahvar and Rezaei, 2020; 
Hassan et al., 2020; Lundstrom et al., 2020; Nejadghaderi et al., 2020; 
Saleki et al., 2020; Seyran et al., 2020; Sharifkashani et al., 2020; Sho-
jaeefar et al., 2021; Pashaei and Rezaei, 2020; Rezaei, 2020a; Seyran 
et al., 2021; Shakerian et al., 2020), non-pharmacological interventions 
(Samieefar et al., 2020; Jabbari et al., 2020b) have been implemented to 
make the diagnosis of infection as early as possible (Rabiee et al., 2020; 
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Basiri et al., 2021; Tantuoyir and Rezaei, 2021) and limit the spread of 
the infection (Prem et al., 2020). Namely, behavioral interventions 
aiming to separate people physically, generally referred to as “social 
distancing” (Galea et al., 2020), are executed so that the interpersonal 
transmission is interrupted. Using masks, self-isolation, and quarantine 
or lockdown of entire cities and communities are some of these strate-
gies (Marais and Sorrell, 2020). 
Quarantine is restricting people who are suspected of having had 
exposure to a contagious disease but are not showing illness as of yet, 
and isolation is separating those who are already ill (Cetron and Land-
wirth, 2005). Quarantine was successfully implemented during the se-
vere acute respiratory syndrome (SARS) epidemic in 2003 (Goh et al., 
2006) as a socially acceptable method (Cetron and Simone, 2004), and 
in the current pandemic, a community-wide quarantine was imple-
mented in several countries; enforced to a magnitude unprecedented to 
mankind (Yousfi et al., 2020). 
It is expected for these new social rules of conduct to come with 
consequences for people on communal and personal levels. The concerns 
grow from not knowing the future situation of our jobs (Schulte, 2020) 
to just wanting to be able to see the light of day outside the confinement 
of our homes (van Houwelingen-Snippe et al., 2020); but as the word 
itself entails, isolation and quarantine lead to being away from our 
communities, and one of the most devastating repercussions of that is a 
crushing feeling of loneliness (van Tilburg, 2020). This sense of 
disconnectedness (Gratz, 2020), together with the stresses and concerns 
during a pandemic (Whitehead and Torossian, 2021), can influence 
mental health (Tso and Park, 2020), and consequently health behaviors 
(Vanderbruggen et al., 2020), and overall physical well-being (Philip 
et al., 2020). The perception of loneliness can affect the function of 
multiple systems in the body, including the cardiovascular system 
(Cacioppo et al., 2002a). It can also be the precipitating factor for 
metabolic syndrome (Whisman, 2010), among other diseases, and can 
lead to increased death rates of all causes (Holt-Lunstad et al., 2015). 
The ways that loneliness can lead to all these poor health outcomes 
are rather complex (Hawkley and Cacioppo, 2003); health behaviors, 
increased stress reaction, and faulty physiological repairing functions 
are the three main suggested pathways to pathology (Cacioppo et al., 
2015). An interesting way that loneliness affects us is in how it changes 
the activities of the immune system. Loneliness can alter adaptive and 
innate immune responses (Matthai and Black, 1993). Perceived loneli-
ness can cause a conserved transcriptional response to adversity (CTRA), 
which promotes inflammation through the increased transcription of 
related genes (Uchida et al., 2018), eliciting an inflammatory response 
through the actions of the sympathetic nervous system (SNS) (Irwin and 
Cole, 2011), and diminishes antiviral responses by decreasing the 
expression of the genes associated with them, leading to inadequate 
protection against viral disease (Uchida et al., 2018). 
Therefore isolation, with its unintended consequences, has inher-
ently paradoxical effects on immunity in relation to viral disease, which 
is very much in line with the pandemic we are currently living through; 
and though this paradox can present a challenge, its acknowledgment 
can nonetheless serve as an opportunity for us to become conscious of 
how the lockdown affects us (Yousfi et al., 2020), and to develop pre-
ventative and therapeutic measures in order to boost the immune system 
and keep it intact (Ranasinghe et al., 2020); by reducing the feeling of 
loneliness and mitigating any adverse effects of it (Razai et al., 2020). 
In this review, we aim to explore, in detail, the pathological effects of 
the lockdown on immunity and present suggested methods to improve 
our physical, psychological, and healthcare abilities to fight viral 
infection in the context of the COVID-19 pandemic. 
2. Origins 
2.1. Emotional aspects of lockdown 
It is human nature to be scared of anything that could potentially 
threaten our survival (Steimer, 2002). There is also an instinctive fear of 
the unknown instilled in all of us (Carleton, 2016), so the emergence of a 
novel, potentially fatal virus left us collectively feeling afraid and 
anxious. The concerns grew more extensive with daily and weekly re-
ports of the newly diagnosed cases and mortalities, and when the 
lockdown was finally enforced (Kumar, 2020), it affected almost every 
aspect of our lives, creating a social situation that was unsettling to all of 
us. 
Months later, now that lockdown has turned into social distancing, 
things still are not back to normal. Our most basic forms of social 
conduct and self-expression have drastically changed. We cannot even 
see each other’s faces with the masks we need to wear, covering more 
than half of our facial expressions, and as a result, masking our emotions 
(Nestor et al., 2020). All of this “distance” is making us feel separated 
and lonely; as if the viral pandemic is ferally molding itself into a 
loneliness epidemic (Hwang et al., 2020; Jeste et al., 2020). 
With the spreading news that older age and underlying diseases led 
to a higher chance of contraction and poorer outcomes (Mueller et al., 
2020), groups that were marginalized in this pandemic, e.g., the elderly 
(Lichtenstein, 2021), had a more challenging time coping, feeling even 
lonelier (Monahan, 2020). Those with chronic illnesses, such as cancer 
and diabetes, also had additional sources of worry, namely the infection 
overly affecting them, being marginalized as a high-risk group, and 
doubting their ability to manage diabetes if they got infected (Joensen 
et al., 2020; Razavi et al., 2021). 
2.2. Psychosocial aspects of immune regulation 
With these emerging physical and social conditions comes the chal-
lenging need to adapt, and this arising challenge matches the exact 
definition of a “psychosocial stressor”; those are situations that put our 
adaptive abilities to the test (Monroe and Slavich, 2016). A psycholog-
ical stressor can be studied from two aspects; one, the quality and 
quantity of the exposure to it, and two, the individual perception of the 
experienced stress (Irwin and Cole, 2011). The latter can often over-
power the former, meaning one’s subjective cognition of a situation, 
regardless of its objective magnitude, gives it meaning, and conse-
quently determines the person’s response to the stressor; thus, people 
react distinctively to psychological stressors (Hawkley and Cacioppo, 
2003). 
This difference in the perception of events and subsequent decision 
making is very much under the influence of the individual’s emotional 
and psychological state (Lerner et al., 2015), and this is exactly where 
the destructive effects of the quarantine unfold, mediated by loneliness. 
Loneliness affects perception in such a way that ordinary events, 
considered regular by most, are more likely to be viewed as stressful 
(Cacioppo, 1994). Therefore loneliness, in and of itself, can be a 
generating source of acute, as well as chronic psychosocial stress 
(Mushtaq et al., 2014). Furthermore, different types of psychosocial 
stressors, such as separation, defeat, loss, rejection, or evaluation in a 
social context, can lead to inflammation, as shown in animal and human 
studies (Eisenberger et al., 2017). 
This consequent psychological and inflammatory response in the 
lonely (Cacioppo, 1994) is evident in their higher increase of pro- 
inflammatory cytokines in the face of social stressors, causing an 
elevated inflammatory response (Audet et al., 2014). This inflammation, 
activated by psychosocial stressors, is caused through two pathways, 
namely the sympathetic nervous system (SNS) and the hypothalamic- 
pituitary-adrenocortical (HPA) axis, which can be activated by central 
neural mechanisms; hence the observed psychological influence (Irwin 
and Cole, 2011). 
2.3. Conserved transcriptional response to adversity (CTRA) 
Functional activation of the human genome is significantly altered in 
different social circumstances (Gibson, 2008). This was first studied in 
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the gene expression of leukocytes (Idaghdour et al., 2010). As touched 
upon earlier, both the physiological and psychological processes in any 
given social situation amount to its total effect, and each of these aspects 
activates different gene modules, along with a conserved generalized 
response to adverse life conditions (Cole, 2013). Of these adverse con-
ditions, social isolation has been thoroughly studied in this regard (Cole 
et al., 2007). More than 200 genes are expressed at significantly 
different levels in chronic social isolation compared to social integration 
(Cole et al., 2011). 
As observed in studies, there was a lower expression of genes related 
to antibody synthesis in objective isolation, which could be due to less 
contact with socially spread microbes, whereas subjective isolation was 
associated with a decreased expression of specific transcripts in immu-
noglobulin G1 (IgG1) synthesis and type I interferon (IFN) genes, and an 
elevated expression of pro-inflammatory genes (Irwin and Cole, 2011; 
Cole, 2013). This socially regulated pattern, called the conserved tran-
scriptional response to adversity (CTRA), involves the β-adrenergic re-
ceptors, the SNS, the HPA axis, and the glucocorticoid response (Holmes 
et al., 2019). 
CTRA and its different implications are of evolutionary advantage 
(Cole et al., 2007). Isolation puts us at a higher risk of getting harmed, i. 
e., attacked or wounded, where we do not have the protective circle of 
others around us (Moieni et al., 2015), and the resulting inflammation is 
the evolutionarily chosen shield of protection, adapted for times of 
loneliness and isolation (Leschak and Eisenberger, 2019). Taken in the 
context of the today world, inflammation heightens trait sensitivity to 
negative social experiences, shifting their perception into the psycho-
logical model of “threat”, and therefore helping the individual avoid 
potentially harmful situations by further favoring isolation (Leschak and 
Eisenberger, 2019). In other words, CTRA itself can lead to self- 
perceived isolation, meaning inflammation, and perceived social stress 
are interconnected, each leading to the other, mediated by CTRA in both 
directions (Cole et al., 2015). 
The diminished socially spread pathogen exposure in isolation re-
duces the need for robust antiviral immunity. Moreover, as potential 
wounding is more likely to occur and possibly more threatening to im-
mediate survival in the context of social isolation, inflammation is 
prioritized at the expense of antiviral response (Leschak and Eisen-
berger, 2019). 
2.3.1. Inflammatory cytokines and immune dysregulation 
When reviewing the COVID-19 pandemic and its accompanying so-
cial issues and psychiatric outcomes with relation to each other, in-
flammatory cytokines and their interaction with neuroendocrine 
components are commonly remarked (Raony et al., 2020). Furthermore, 
loneliness and inflammation have been found correlated (Leschak and 
Eisenberger, 2019; Moieni and Eisenberger, 2018; Brown et al., 2020), 
such that loneliness enhances inflammatory responses to an acutely 
stressful event (Brown et al., 2018), such as biological challenges, e.g., 
endotoxin (Jaremka et al., 2013a). Stress and troubled interpersonal 
connections could possibly heighten inflammatory responses synergis-
tically (Jaremka et al., 2013a). Pro-inflammatory cytokines such as TNF- 
α (Moieni et al., 2015; Jaremka et al., 2013b), IL-6 (Moieni et al., 2015; 
Jaremka et al., 2013b; Smith et al., 2020a; Hackett et al., 2012; Theeke 
et al., 2016; Nersesian et al., 2018; Balter et al., 2019; Loucks et al., 
2006) and acute-phase reactants such as CRP (Nersesian et al., 2018; 
Loucks et al., 2006; Vingeliene et al., 2019), fibrinogen (Nersesian et al., 
2018; Steptoe et al., 2004; Mezuk et al., 2016) and IL-1RA (Hackett 
et al., 2012) levels have been found significantly affected by loneliness. 
Social isolation as a form of prolonged and chronic stress leads to 
sustained activation of the HPA axis, resulting in a reduced allostatic 
negative feedback through the elaboration of cortisol. This allostatic 
overload results in a down-regulation of the glucocorticoid receptor 
gene, namely NR3C1 (Cole et al., 2012). This phenomenon is referred to 
as functional glucocorticoid desensitization (Cole et al., 2015) and has 
been implicated in the context of CTRA gene expression (Holmes et al., 
2019). 
2.3.2. Antiviral immune response 
With the evolutionary explanation mentioned earlier, antiviral ac-
tivity is diminished both in loneliness and social isolation (Leschak and 
Eisenberger, 2019), with the down-regulation of type I and II IFNs (Cole 
et al., 2015). This inadequate antiviral immunity has been studied with 
regard to the immune response to different viruses, which has been 
found impaired in infection with simian immunodeficiency virus (SIV) 
(Cole et al., 2015). Elevated antibody titers against some ubiquitous or 
latent viruses (Hodel and Grob, 1993), such as higher CMV antibody 
titers (Glaser et al., 1985) have been associated with a more severe 
symptom cluster of depression, fatigue, and pain (Jaremka et al., 
2013c), and higher EBV (Glaser et al., 1985) and HSV-1 antibody titers 
(Glaser et al., 1985; Jaremka et al., 2018) have also been observed in 
lonelier individuals. 
With loneliness causing a poorer subjective adaptation to stressful 
challenges, another observed aspect of immune dysregulation, rather 
than suppression, is that the balance between type 1 (IFN-gamma) and 
type 2 (IL-10) cytokines shifts toward type 2 in stress, and this could be a 
potential explanation for the higher observed type 2 mediated immune 
reactions in times of elevated stress, such as viral infection, expression of 
latent viruses, autoimmunity and allergic or asthmatic reactions 
(Marshall Jr et al., 1998). 
It is rather unfortunate that infection with viruses of social stigma, 
such as HIV or HCV, consequently leads to further isolation and loneli-
ness. The mere diagnosis of HCV has been associated with feelings of 
loneliness and social isolation (Montague et al., 2019), and it is much the 
same when living with HIV through the years (Brown et al., 2019). The 
internalized stigma of HIV infection and subsequent suboptimal adher-
ence to antiretroviral therapy is another studied situation in this context 
(Enriquez et al., 2019; Turan et al., 2016; Rendina et al., 2019). The 
same phenomenon with the stigma has been happening with a COVID- 
19 diagnosis (Sotgiu and Dobler, 2020). Loneliness has been found 
related to lower preventative behaviors toward infection during COVID- 
19 (Stickley et al., 2021), which leads us to believe that the relation 
between antiviral immunity and loneliness, although controlled differ-
ently in each direction through distinct mechanisms of immunity and 
behavior, is nonetheless reciprocal. 
2.3.3. Innate and adaptive immunity 
Loneliness can affect the proper activity of innate immunity through 
reduced natural killer cell functionality (Kiecolt-Glaser et al., 1984), and 
cellular and humoral immunity, through decreased plasma IgG, IgM 
(Dénes, 1980), and IgA (Dénes, 1980) levels and diminished lymphocyte 
activity such as decreased mitogen stimulation (Hodel and Grob, 1993). 
Focusing again on CTRA, another way it affects immunity is through 
transcriptome shifts that are primarily mediated by myeloid lineage 
immune cells, e.g., dendritic cells and monocytes (Cole et al., 2011), and 
it has been confirmed, through studies on isolated subpopulations of 
leukocytes, that changes in transcription in response to human social 
adversity are mediated by monocytes (Miller et al., 2008; O’Donovan 
et al., 2011). In addition, animal models have shown an up-regulation in 
the production of distinct, immature, pro-inflammatory monocytes by 
the SNS through changing hematopoietic mechanisms, mediated by 
β-adrenergic signals that enhance the differentiation and development 
of monocytes through increased transcription of the myelopoietic 
growth factor, granulocyte-macrophage colony-stimulating factor (GM- 
CSF) (Powell et al., 2013). GM-CSF has been associated with loneliness 
in other studies as well (Henneghan et al., 2020). 
2.4. Lifestyle, health behaviors, and the psychodynamics of social 
distancing 
Along with the aforementioned immunological adaptations to the 
newly set social circumstances, it is vital to take consequent behavioral 
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and environmental changes into account when analyzing the COVID-19 
situation (Emerson, 2020). 
2.4.1. Eating habits 
Keeping a healthy diet has proven to be exceedingly difficult during 
the pandemic (Jayawardena and Misra, 2020). The main changes in diet 
have been a lower intake of fresh fruits, vegetables, and protein-rich 
foods of high quality, e.g., fish or meat, and higher consumption of 
snacks and sugary, high-fat foods, making the diet progressively 
imbalanced. These changes can possibly affect immunity and the man-
agement of chronic underlying diseases, subsequent to inadequate 
content of micronutrients and the resultant disproportionate calorie 
intake (Jayawardena and Misra, 2020), eventually leading to a lack of 
sufficient nutrients to support the immune system (Nieman and Bishop, 
2006) and causing weight gain (Zachary et al., 2020), respectively. 
The use of food as a defective coping mechanism to re-establish a 
sense of control over the uncertain circumstances we are currently living 
through is possible and should be carefully considered regarding those 
with eating disorders (Schlegl, 2020). 
2.4.2. Sedentary lifestyle and inactivity 
The catastrophic lifestyle changes in the settings of COVID-19 have 
led to increased sedentary behavior and decreased levels of physical 
activity (Zheng et al., 2020), and resultant weight gain (Zachary et al., 
2020). These behaviors come with consequences for the immune system, 
causing immunosuppression through a heightened inflammatory state, 
oxidative stress, and other processes (Booth et al., 2017), thus making 
the individual more susceptible to viral infection (Luzi and Radaelli, 
2020). In contrast, increased levels of physical activity have been shown 
to improve markers of immunity, leading to lower levels of inflamma-
tory markers, namely CRP, IL-6, IL-18, and TNF-α, along with decreased 
leukocyte counts (Wedell-Neergaard et al., 2018). 
A mediator for the effects of sedentarism on immunity, especially 
during a viral pandemic, is obesity (Luzi and Radaelli, 2020). In an 
article on influenza and influenza-like viruses, a reciprocal connection 
between viral infection and obesity was observed, meaning the illness 
would lead to obesity, and obesity, in turn, through prolonged viral 
shedding, increased viral load in a breath, and higher viral variability, 
caused greater spread of the infection (Luzi and Radaelli, 2020). 
2.4.3. Sleep disturbances 
Sleep disturbances and insomnia are of the common consequences of 
quarantine, experienced by many (Kokou-Kpolou et al., 2020). Loneli-
ness due to COVID-19 is associated with more troubles around sleep 
(Grossman et al., 2021). Higher scores of insomnia have been reported 
among people with concerns of having themselves or a loved one been 
infected. Other predictors of insomnia are loneliness, heightened intol-
erance to uncertainty, worries of COVID-19, and higher severity of 
depression (Voitsidis et al., 2020). As sleeping is arguably the most basic 
behavior of restorative value, the resultant sleep deprivation, as seen in 
the times of COVID-19 and loneliness (Cacioppo et al., 2002b), can 
impair immune functions through decreased cytokine release (Bryant 
et al., 2004). 
Moreover, increased duration of sleep has been observed in a study 
on nursing students. This is concurrent with a longer time spent in bed 
and increased sleep latency, meaning it takes longer for them to fall 
asleep; therefore, sleep efficiency, which is the ratio between time spent 
asleep and time spent in bed, is lower in lockdown (Romero-Blanco 
et al., 2020). 
2.4.4. Mental health 
As with the stresses of contagion and stay-at-home orders, daily life 
took on a completely different look in lockdown (Tull et al., 2020), with 
the isolation consequently affecting mental health (Ustun, 2020). Poor 
mental health outcomes have been thoroughly studied in the context of 
COVID-19, from loneliness, anxiety, and depression (Gorenko, 2021) to 
suicidal ideation (Lewis, 2020). Self-reported alcohol and substance use 
increased significantly in lockdown due to boredom, loneliness, a lack of 
social contact, or loss of daily structure (Vanderbruggen et al., 2020). 
Lack of movement and long hours of sitting were associated with worse 
depression, stress, and loneliness, as self-reported physical activity 
among previously active people was significantly lower after the 
pandemic (Meyer et al., 2020). A higher screen time had the same 
mental health outcomes (Meyer et al., 2020). 
Social adversity, with its resultant inflammatory response through 
CTRA, as discussed earlier in the case of loneliness, could also be a cause 
for the development of anxiety and consequent depression, and has been 
studied as an etiological theory for depression (Slavich and Irwin, 2014). 
This theory can explain the emergence of depression and anxiety in the 
settings of COVID-19. However, it also signifies the shared underlying 
pathology and resultant compromise of the immune system in social 
isolation, anxiety, and depression, portraying them as conjoined phe-
nomena in mental health outcomes of COVID-19. 
It is worth noting that self-isolation and quarantine lead to more 
severe depression and anxiety in comparison with social distancing 
(Meyer et al., 2020), which could also be explained by the theory 
mentioned above, with regard to levels of social adversity and human 
connection in each of those settings. Furthermore, social platforms also 
play a major role in people’s emotional response to the pandemic, as one 
might feel fear by obtaining fake news about the disease (Jain et al., 
2020; Fernández-Torres et al., 2021), and so the infodemic has further 
worsened the fears of the pandemic , and appears to be immensely 
detrimental to mental health. 
2.5. COVID-19 and immune dysregulation 
When investigating immunity against COVID-19, the very nature of 
the disease should also be taken into consideration. The virus attacks the 
immune system in such a way that results in a systemic inflammatory 
response, with disproportionately high levels of inflammatory cyto-
kines, often referred to as a “cytokine storm,” which is one of the most 
prominent features of the disease and can ultimately lead to severe 
COVID-19 outcomes like the acute respiratory distress syndrome (ARDS) 
(Coperchini et al., 2020). In severe cases of COVID-19, macrophage 
activation syndrome, along with NK cell and CD4 cell lymphopenia, are 
also present, ultimately leading to a major dysregulation of the immune 
system (Giamarellos-Bourboulis et al., 2020). 
This pro-inflammatory profile, along with the impaired immunity, is 
also present in people with certain conditions like obesity, which is 
associated with chronic low-grade systemic inflammation and conse-
quently poorer COVID-19 outcomes (Chiappetta et al., 2020), or in times 
of social isolation or loneliness (Leschak and Eisenberger, 2019; Moieni 
and Eisenberger, 2018; Brown et al., 2020), which are all prevalent 
observations in times of COVID-19. 
The cytokine storm in COVID-19 almost imitates an exaggerated 
image of the aforementioned pro-inflammatory profile. This shared 
pathology of the immune system, present in different magnitudes, makes 
the impaired immune profile in the social settings of COVID-19 almost 
look like an invitation to a more drastic progression of symptoms in the 
case of contraction, given that a basic level of dysregulation is already 
present and is more likely to be exacerbated. Likewise, the virus itself 
and its social consequences compound each other’s negative effects. 
Taken together, the aforementioned psychosocial factors lead to an 
altered immunoemotional regulatory system (IMMERS, (Saghazadeh 
and Rezaei, 2019)) in times of COVID-19, making the achievement of 
immunity against this ferocious virus an even tougher fight. 
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3. Therapeutic opportunities 
3.1. Nutraceuticals, functional foods, and dietary recommendations 
3.1.1. Micronutrients and nutraceuticals 
Nutrients are essential to the immune system, as they are needed in 
cell division and cytokine and antibody production and release (Nieman 
and Bishop, 2006). The importance of micronutrients is evident in their 
necessary presence for many enzymes to function properly. Select vi-
tamins and minerals have been known for their roles in maintaining the 
functionality of the immune system, of which are zinc, iron, selenium, 
copper (Raha et al., 2020), and vitamins A, B2, B6, B12, C, D, and E 
(Calder and Kew, 2002; Gulhane and Hiware, 2020). Therefore, a diet 
that provides the necessary nutrients is recommended to boost immunity 
against viral infection (Calder et al., 2020). 
Viral and bacterial infections cause an immune response marked by 
the production of inflammatory cytokines. This is also the case in 
COVID-19 patients who often display increased pro- and anti- 
inflammatory cytokines (Huang et al., 2020). It becomes even more 
vital in those with a severe disease who require intensive care unit (ICU) 
admission and nutritional interventions via enteral tubes, and therefore 
guidelines and recommendations have emerged for this purpose (Min-
nelli et al., 2020). 
The production of pro-inflammatory cytokines, namely TNF-α and 
IL-1, has been found inhibited by vitamin D (Sharifi et al., 2019), in 
addition to its other anti-inflammatory effects (Topilski et al., 2004). 
Vitamin D can also help maintain pulmonary arterial blood pressure and 
inhibit cystic fibrosis and emphysema (Roselin and Parameshwari, 
2020), through regulating the renin-angiotensin system (Li, 2003), thus 
strengthening the lungs (Roselin and Parameshwari, 2020). Deficiency 
of vitamin D could lead to an increased risk of infection, especially in the 
respiratory system (Laaksi et al., 2007; Karatekin et al., 2009); therefore, 
vitamin D has been suggested as a preventative factor in the face of 
COVID-19 (Grant et al., 2020) and also in mitigating the potentially 
deleterious outcomes (Razdan et al., 2020), so sun exposure in times of 
quarantine or taking vitamin D supplements should be considered 
(Yousfi et al., 2020). The recommended guideline for people at risk of 
infection is rapidly raising vitamin D concentrations by taking 10,000 
IU/d of vitamin D3, reduced to 5000 IU/d after a few weeks, with the 
goal concentration being above 40–60 ng/mL (100–150 nmol/L) (Grant 
et al., 2020). 
Vitamin C, present in citrus fruits, acts as an antioxidant and is also 
well-known for its therapeutic effects on upper respiratory tract in-
fections (URTIs), reducing both the severity of symptoms and duration 
of the illness (Aldrin Joshua et al., 2020). 
Melatonin has also been studied in this regard. Melatonin can reju-
venate the glutathione redox system and restore the function of neu-
trophils in times of heightened oxidative stress, and therefore has been 
hypothetically suggested as a potential immune booster in the face of 
COVID-19 (NaveenKumar et al., 2020). 
3.1.2. Functional foods 
In the pursuit of an intact host defense against COVID-19, dietary 
recommendations other than micronutrient supplementation have also 
been studied. 
Functional foods are foods with biologically active ingredients. They 
are physiologically beneficial to health and can help prevent chronic 
diseases, namely, type 2 diabetes mellitus (Alkhatib et al., 2017). Some 
functional foods have been associated with anti-inflammatory and anti- 
oxidative properties, such as polyphenol-rich herbs, e.g., coffee and 
green or black tea (Alkhatib et al., 2017), or antimicrobial properties 
such as bioactive peptides in natural food proteins, which are also 
available as nutraceuticals (Acquah et al., 2020). These properties could 
potentially be protective against COVID-19. 
Of the functional foods that have been studied in light of the immune 
system and used as immune boosters are spices and herbs. Higher 
ginger, turmeric, garlic, curcumin, and cloves consumption have been 
found associated with fewer COVID-19 cases per million population 
(Elsayed and Khan, 2020). Curcumin was studied both when used with 
zinc, as an immunity booster (Roy, 2020), and alone, showing additional 
anti-depressant properties (Soni et al., 2020). Garlic has been recom-
mended in times of COVID-19 for having antimicrobial, anti- 
inflammatory, and all-around immunomodulatory properties (Donma 
and Donma, 2020). 
Items of traditional herbal medicine have also been studied as im-
mune boosters in the fight against COVID-19, namely propolis, which is 
the resinous substance that bees make from botanical exudates (Berretta 
et al., 2020). 
3.1.3. Recommended eating patterns 
Eating patterns such as intermittent fasting (IF) and calorie restric-
tion (CR), have been suggested as methods to boost immunity. IF was 
found to affect immunity in multiple regards, affecting inflammation 
and oxidative stress, metabolic rate, and body weight, as well as 
composition (Faris et al., 2020). Inflammation, for example, was 
depressed with IF, as shown in reduced CRP and IL-6 levels in prolonged 
(Aksungar et al., 2007) and short-term IF (Brannon et al., 2009). Other 
markers of inflammation (TNF-α), along with oxidative stress bio-
markers such as nitrotyrosine, 8-isoprostane and protein carbonyls, and 
metabolic markers such as serum cholesterol and triglycerides, were also 
reduced with an alternate-day pattern of CR, which led to better medical 
outcomes in patients with asthma (Johnson et al., 2007). 
IF can activate immune responses (Cheng et al., 2014) and induce 
autophagy, which is the elimination of dysfunctional organelles and 
proteins, as well as invading pathogens (Bagherniya et al., 2018), and 
through distinct mechanisms, stimulates the immune system and primes 
host defense; therefore, along with the other aforementioned effects, IF 
could be a potential preventative approach to COVID-19 (Hannan et al., 
2020). However, this is not recommended for everyone, as spontaneous 
fasting could have adverse effects even among healthy individuals. 
Moreover, the CR that happens in IF can be detrimental to the condition 
of underlying diseases and it is strongly advised for COVID-19 patients 
not to fast, as there is a risk of inadequate nutrient supply (Hannan et al., 
2020). The net benefits of IF in prevention of COVID-19 should be 
further studied appropriately. 
3.2. Adapting to the new manner of living 
3.2.1. Exercise and physical activity 
The previously mentioned immune consequences of obesity due to 
physical inactivity can be mitigated by moderate physical exercise and 
drugs commonly used in the treatment of obesity-related diabetes, 
namely metformin and pioglitazone (Luzi and Radaelli, 2020). Although 
any physical exercise can be considered favorable compared to inac-
tivity in times of COVID-19 (Alkhatib, 2020), it is vital to keep a certain 
level of physical activity to mitigate the immune consequences of 
inactivity and isolation (Simpson and Katsanis, 2020). 
In terms of exercise recommendations in these conditions, a mild to 
moderate intensity has been suggested, as excessive exercise may 
negatively affect immunity through subsequent higher cortisol levels 
(Codella et al., 2015) and an increased risk of infection (Simpson et al., 
2020). It is advisable to exercise at home, not to put oneself at the risk of 
exposure to the airborne virus. Targeting balance, strength, control, 
stretching, or a mix of these, some of the activities achievable at home 
are those using own body weight, such as sit-ups, push-ups, chair squats, 
climbing the stairs, lunges, or just walking around the house. One could 
also choose to walk to necessary places like the store and carry the 
groceries as a weight-bearing exercise (Chen et al., 2020). To keep the 
recommended moderate intensity, the exercise should use 64-76% of the 
maximum heart rate, which can be calculated individually by sub-
tracting one’s age from 220 (American College of Sports et al., 2018). 
A gradually increased exercise volume during lockdown can cause a 
H. Pourriyahi et al.                                                                                                                                                                                                                             
Journal of Neuroimmunology 356 (2021) 577578
6
higher maximal oxygen consumption (V O2max) (Alkhatib, 2020). This 
can be particularly beneficial in individuals who have had low-grade 
inflammation for a long time, with more inflammasomes and higher 
pro-inflammatory cytokine levels, and are susceptible to higher risks of 
infection and poorer outcomes, i.e., those with obesity, diabetes, and 
metabolic syndrome (Zbinden-Foncea et al., 2020). 
3.2.2. Sleep recommendations 
With the previously mentioned immune advantages of adequate 
sleep and the observed sleep disturbances in times of COVID-19 
(Cacioppo et al., 2002b), maintaining a healthy sleep pattern should 
be prioritized. The recommended sleep duration for adults is usually 7–9 
h per night, though this depends on age, gender, and physical activity 
and should be individualized (Hirshkowitz et al., 2015). 
3.3. Suggestions for better mental health and reducing the feeling of 
loneliness 
The current circumstances demand different strategies for different 
groups of people to cope (Hiremath et al., 2020). WHO has shared 
mental health considerations for the general population, advising to 
minimize their exposure to outbreak news to reduce anxiety, and for 
healthcare workers, recommending them to take care of themselves and 
rest between shifts, along with considerations for other groups (Orga-
nization, 2020). 
Certain groups of people, namely adults who live alone, those with 
lower income, and young adults (18–30 years old), are known to be 
more likely to experience loneliness, and these groups are even more at 
risk of loneliness during the COVID-19 pandemic. In addition, other 
groups, e.g., students, also felt lonelier during lockdown than before the 
pandemic. It has been suggested that interventions to mitigate loneliness 
should first target these groups of people (Slavich and Irwin, 2014). The 
COVID-19 pandemic has made feelings of loneliness and social isolation 
more prominent, and various interventions in this regard have been 
studied, namely social prescription by medical professionals, individual 
and group-oriented therapy, and different strategies involving infor-
mation and communication technologies (ICT). However, there is still 
uncertainty about which of these methods works best for each target 
group (Smith and Lim, 2020). Nonetheless, the stressors present in the 
context of COVID-19 implicate the urgent need to focus on resilience, 
both on an individual and a societal level (Vinkers et al., 2020). 
3.3.1. Social prescribing 
Social prescribing is incorporating non-medical interventions, e.g., 
physical activities, the arts, or other forms of engaging with the com-
munity, in the course of therapy, to tackle more extensive determinants 
of health while turning to resources that are already present in com-
munities, and thus improving well-being (Razai et al., 2020). 
A study suggests turning to poetry to combat loneliness in these times 
of solitude (Xiang and Yi, 2020). Singing was also utilized in the COVID- 
19 lockdown, as the silence of Italian cities was broken by people singing 
together, apart, each at their own windows, bringing people together at 
heart and improving the feeling of social cohesion (Corvo and De Caro, 
2020). Along with these social suggestions, dog ownership was also 
found to be protective against loneliness for people living alone in times 
of COVID-19 (Oliva and Johnston, 2020). 
3.4. Telemedicine 
Telemedicine can be defined as the act of health care professionals 
providing health care services through the use of ICT, so that valid in-
formation is being exchanged, where there is distance between the 
provider and the recipient of the care (eHealthe, 2010). The distancing 
nature of the new social norms demanded new ways of health care de-
livery, as those not infected with the virus, and even more so people at 
higher risks of infection, like people with underlying diseases, still 
required care from their medical professionals without risking exposure 
in hospitals (Smith et al., 2020b); thus remotely-delivered interventions 
were necessary during the COVID-19 lockdown (Gorenko, 2021; 
Moazzami et al., 2020). 
The remote management of people with chronic diseases through 
telemedicine has been studied prior to this situation (Bashshur et al., 
2014), and has been brought to attention in times of COVID-19 for the 
management of type 1, type 2, and gestational diabetes (Torlone et al., 
2020), and in programs to decrease anxiety in at-risk patients with 
scleroderma (Thombs et al., 2020). 
3.4.1. Telepsychiatry 
With the strain of COVID-19 on mental health and the lack of im-
mediate access to necessary psychiatric care, the use of telemedicine in 
the context of psychiatry, referred to as telepsychiatry, has been studied. 
However, it is still underused and can be potentially promoted in current 
circumstances (Di Carlo, 2020). The emotional, interpersonal, and 
economic burden of the current living conditions has led to neglect and 
thus worsening of mental health and ultimately a higher risk of suicide, 
as mentioned earlier. Therefore, proper follow-up is vital in the face of 
psychiatric disorders, and telemedicine can be a useful platform in 
ensuring this aim in times of COVID-19 (Wasserman et al., 2020). 
Brief 30-min phone calls with clinicians were studied as a connection 
plan to provide care during social distancing restrictions, thus reducing 
the risk of suicide (Van Orden, 2020). As regular visits are also required 
in patients with psychosis for their treatment and preventing relapse, an 
intervention called “Phone Pal” was studied to provide communication 
between patients and volunteers, as these patients are particularly iso-
lated in their daily lives and face social stigma. However, the interven-
tion can be implemented for other disorders as well (Pinto da Costa, 
2020). Dialectical behavior therapy, a type of cognitive-behavioral 
therapy, was also studied among patients with borderline personality 
disorder, before and during confinement. During the confinement period 
of 8 weeks, video and phone calls were used, and patients felt decreased 
levels of fear and tension and had lower addictive or compulsive be-
haviors like alcohol consumption or binge-eating, along with an 
increased feeling of distress, which could be associated with loneliness 
(Salamin, 2021). 
3.5. Interventions aimed at the elderly 
Among people aged 60 and older, COVID-19 has been observed to 
have substantially higher infection rates, symptom severity, and mor-
tality (Tian et al., 2020). Comorbidity is the main cause of this obser-
vation. However, it could also be attributed to immunosenescence, 
which is the decline in the immune system of the elderly and the overall 
consequences of aging such as lower fitness and general functionality 
along with the resultant frailty and weakness. Immunosenescence can 
also affect response to vaccination and the outcome of infectious dis-
eases (Zhavoronkov, 2020). 
Moreover, an individual’s subjective age can affect the association 
between perceived feelings of isolation or loneliness, and the observed 
psychiatric symptoms during the COVID-19 pandemic; meaning, 
compared to their actual age, those who felt younger showed a weaker 
correlation between loneliness and psychiatric symptoms, and those 
feeling older showed a stronger association. In other words, those with 
an older age identity are at higher risk of loneliness affecting their 
mental health. Therefore, higher subjective, as well as objective, age can 
be risk factors for adverse effects of loneliness in times of COVID-19 
(Shrira, 2020). 
This explains the need for interventions aimed at the elderly, to 
mitigate the increased feeling of loneliness during the pandemic in this 
population; many of whom live in nursing homes and may therefore be 
feeling even lonelier. To fight this feeling of isolation, self-guided ther-
apy sessions, along with interventions involving phone calls and video 
calls, have been suggested (Gorenko, 2021). To name a few, “The 
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Telephone Outreach in the COVID-19 Outbreak Program” implemented 
weekly phone calls for the elders at nursing homes to talk with volunteer 
students, which resulted in the senior residents looking forward to 
phone calls every week and feeling more socially connected (van Dyck 
et al., 2020). “TOVID” (Telephony Or Videophony for Isolated elDerly) 
provided the same aim. Compared to video calls, telephone calls proved 
easier to handle independently and were used more frequently among 
the elderly in hospitals, long-term care, and nursing homes. Both mo-
dalities were equally satisfying overall, though video calls were even 
more favored by the nursing home and long-term care residents, when 
given help with establishing the call (Sacco et al., 2020). 
There is also the need for social workers to be trained in practices 
involving the elderly, regarding subjects that were highlighted in times 
of COVID-19, namely ageism, loneliness, the use of technology, and the 
required collaborative practice between those of different professions 
(Berg-Weger and Schroepfer, 2020). 
4. Conclusion 
COVID-19 can severely affect immune regulation (Mohamed et al., 
2020a; Torabi-Rahvar and Rezaei, 2020; Lundstrom et al., 2020; 
Nejadghaderi et al., 2020; Shojaeefar et al., 2021; Delavari et al., 2020; 
Nasab et al., 2020; Sahu et al., 2020; Bahrami, 2020; Fathi and Rezaei, 
2020; Jenab, 2020; Saghazadeh and Rezaei, 2020b; Sarzaeim and 
Rezaei, 2020; Yazdanpanah et al., 2020a; Yazdanpanah et al., 2020b; 
Darbeheshti and Rezaei, 2020; Ahanchian, 2020; Goudarzi, 2020; Hei-
darpour et al., 2020; Khosroshahi and Rezaei, 2020; Yousefzadegan and 
Rezaei, 2020; Aleebrahim-Dehkordi et al., 2020; Babaha and Rezaei, 
2020; Rezaei, 2020b; Darbeheshti, 2021; Khanmohammadi and Rezaei, 
2021; Moradian et al., 2020b), as it involves multiple organs (Nejad-
ghaderi et al., 2020; Goudarzi, 2020; Heidarpour et al., 2020; Hessami, 
2020; Vakhshoori et al., 2020; Jahanshahlu and Rezaei, 2020b; Lotfi and 
Rezaei, 2020b; Jabalameli et al., 2021; Safdarian et al., 2020; Torabi 
et al., 2020), namely the central nervous system (Amanat et al., 2021; 
Sadeghmousavi and Rezaei, 2020b; Saghazadeh and Rezaei, 2021). 
During the pandemic, health polices at both national and international 
levels (Nejadghaderi et al., 2021; Kafieh et al., 2021) and related social 
consequences have changed almost every aspect of our lives, leading to 
feelings of anxiety, loneliness, isolation (van Tilburg, 2020), and stress 
(Salehi et al., 2021). Altogether, the pandemic of COVID-19 has become 
a live enemy to our IMMERS (Saghazadeh and Rezaei, 2019). The pre-
sent review concluded that the adverse effects of isolation could be 
mitigated through health behaviors. Armed with the capacity to utilize 
the suggested methods, we can aim for a robust immune system and 
fight this battle (Mohamed and Rezaei, 2020), which has persisted for a 
year now (Jabbari and Rezaei, 2020). Pro-sensing biomaterials are of 
emerging interest that can accelerate the early immune responses 
(Saghazadeh and Rezaei, 2021), while testing the clinical efficacy of a 
variety of ancient and modern therapies that selectively modulate 
inflammation remains under investigation (Pezeshki and Rezaei, 2021; 
Zarandi et al., 2021; Palit, 2021; Peymani et al., 2021). 
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